Skip to search formSkip to main contentSkip to account menu

Vioxx

Known as: Merck Frosst brand of rofecoxib, Merck brand of rofecoxib, Merck Sharp & Dhome brand of rofecoxib 
a kind of nonsteroidal anti-inflammatory drugs
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

rofecoxib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women.
2010
2010
Academic Fraud Today: Its Social Causes and Institutional Responses
INTRODUCTION In this Article, I shall address a topic that we should all like to sweep under the rug if it were possible… 
Highly Cited
2007
Highly Cited
2007
Drug risks and free speech--can Congress ban consumer drug ads?
Real-life and longer-term safety studies are often in progress when direct-to-consumer advertising for a new drug begins. The… 
2005
2005
Role of cyclooxygenase-2 in deoxynivalenol-induced immunoglobulin a nephropathy.
2004
2004
Market Withdrawal of Vioxx: Is it Time to Retihink the Use of COX-2 Inhibitors?
On September 30, 2004, Merck and Co. Inc., the manufacturer of the arthritis drug rofecoxib (Vioxx), announced the worldwide… 
2002
2002
Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive
Highly Cited
2001
Highly Cited
2001
Ischemic preconditioning, the most effective gastroprotective intervention: involvement of prostaglandins, nitric oxide, adenosine and sensory nerves.
2001
2001
LC determination of rofecoxib in bulk and pharmaceutical formulations.
2001
2001
Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.
OBJECTIVE To compare the incidence of selected spontaneously reported adverse events (AEs) in patients with osteoarthritis (OA… 
2000
2000
Determination of rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)